Athos Capital Ltd

Position in FOLD — AMICUS THERAPEUTICS, INC.

CIK 1681662 HONG KONG, K3

Position in FOLD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$10,056,930

+$1,512,930 QoQ

Shares Held

695,500

+15.9% QoQ

Ownership

0.221%

of shares outstanding

% of Portfolio

3.27%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Athos Capital Ltd holds $22,540,765 across 4 Biotechnology names. FOLD ranks #1 (44.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC. This page	695,500	$10,056,930
2	ACLX	Arcellx, Inc.	64,900	$7,451,818
3	RVMD	Revolution Medicines, Inc.	36,900	$3,588,525
4	RNA	Atrium Therapeutics, Inc.	107,965	$1,443,492

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,056,930	695,500	+15.9%	Shares	Sole	2026-05-13
2025-12-31	$8,544,000	600,000	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.